0001611793-24-000001.txt : 20240312 0001611793-24-000001.hdr.sgml : 20240312 20240312100943 ACCESSION NUMBER: 0001611793-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 EFFECTIVENESS DATE: 20240312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONL Therapeutics, Inc. CENTRAL INDEX KEY: 0001611793 ORGANIZATION NAME: IRS NUMBER: 464627845 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-507285 FILM NUMBER: 24740534 BUSINESS ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: BUILDING 520, SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 BUSINESS PHONE: 734-926-5530 MAIL ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: BUILDING 520, SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 D 1 primary_doc.xml X0708 D LIVE 0001611793 ONL Therapeutics, Inc. 524 S. Main Street Suite 110 Ann Arbor MI MICHIGAN 48104 734-412-8787 DELAWARE None None Corporation true David Esposito 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Executive Officer Director David Zacks 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Executive Officer Director Mark Hooper 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Director Stella Robertson 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Director Bill Burns 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Director Constance Chang 524 S. Main St Suite 110 Ann Arbor MI MICHIGAN 48104 Executive Officer Biotechnology Decline to Disclose 06b false 2024-02-29 false true false 0 10000000 9999948 52 false 35 0 0 0 false ONL Therapeutics, Inc. David Esposito David Esposito CEO & President 2024-03-12